FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000SQ4S559

Market Closed - Deutsche Boerse AG 01:13:20 26/06/2024 am IST
10.11 EUR +13.09% Intraday chart for FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month-3.35%
1 month-1.37%
Date Price Change
25/24/25 10.11 +13.09%
24/24/24 8.94 -3.04%
21/24/21 9.22 -4.95%
20/24/20 9.7 -11.82%
19/24/19 11 -0.45%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 01:13 am IST

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
WKN SQ4S55
ISINDE000SQ4S559
Date issued 24/11/2022
Strike 176.8 $
Maturity Unlimited
Parity 1 : 1
Emission price 10.07
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 27.56
Lowest since issue 4.79
Spread 0.08
Spread %0.80%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
147.2 USD
Average target price
171.7 USD
Spread / Average Target
+16.66%
Consensus